Potential Association Of Lmna-Associated Generalized Lipodystrophy With Juvenile Dermatomyositis
Tarih
2018Yazar
Sahinoz, Melis
Khairi, Shafaq
Cuttitta, Ashley
Brady, Graham F.
Rupani, Amit
Meral, Rasimcan
Tayeh, Marwan K.
Thomas, Peedikayil
Riebschleger, Meredith
Camelo-Piragua, Sandra
Innis, Jeffrey W.
Bishr Omary, M.
Michele, Daniel E.
Oral, Elif A.
Üst veri
Tüm öğe kaydını gösterÖzet
Background Juvenile dermatomyositis (JDM) is an auto-immune muscle disease which presents with skin manifestations and muscle weakness. At least 10% of the patients with JDM present with acquired lipodystrophy. Laminopathies are caused by mutations in the lamin genes and cover a wide spectrum of diseases including muscular dystrophies and lipodystrophy. The p.T10I LMNA variant is associated with a phenotype of generalized lipodystrophy that has also been called atypical progeroid syndrome. Case presentation A previously healthy female presented with bilateral proximal lower extremity muscle weakness at age 4. She was diagnosed with JDM based on her clinical presentation, laboratory tests and magnetic resonance imaging (MRI). She had subcutaneous fat loss which started in her extremities and progressed to her whole body. At age 7, she had diabetes, hypertriglyceridemia, low leptin levels and low body fat on dual energy X-ray absorptiometry (DEXA) scan, and was diagnosed with acquired generalized lipodystrophy (AGL). Whole exome sequencing (WES) revealed a heterozygous c.29C > T; p.T10I missense pathogenic variant in LMNA, which encodes lamins A and C. Muscle biopsy confirmed JDM rather than muscular dystrophy, showing perifascicular atrophy and perivascular mononuclear cell infiltration. Immunofluroscence of skin fibroblasts confirmed nuclear atypia and fragmentation. Conclusions This is a unique case with p.T10I LMNA variant displaying concurrent JDM and AGL. This co-occurrence raises the intriguing possibility that LMNA, and possibly p.T10I, may have a pathogenic role in not only the occurrence of generalized lipodystrophy, but also juvenile dermatomyositis. Careful phenotypic characterization of additional patients with laminopathies as well as individuals with JDM is warranted. Electronic supplementary material The online version of this article (10.1186/s40842-018-0058-3) contains supplementary material, which is available to authorized users.
Bağlantı
https://doi.org/10.1186/s40842-018-0058-3https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870259/
http://hdl.handle.net/11655/14757